221 related articles for article (PubMed ID: 9635151)
1. Inhibitory effects of candesartan on responses to angiotensin peptides in the hindquarters vascular bed of the cat.
Lambert DG; Champion HC; Kadowitz PJ
Can J Physiol Pharmacol; 1998 Feb; 76(2):133-40. PubMed ID: 9635151
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the effects of candesartan on responses to angiotensin II in the hindquarters vascular bed of the cat.
Champion HC; Bivalacqua TJ; Lambert DG; McNamara DB; Kadowitz PJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S101-3. PubMed ID: 9892149
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the effects of candesartan in the mesenteric vascular bed of the cat.
Champion HC; Kadowitz PJ
Hypertension; 1997 Nov; 30(5):1260-6. PubMed ID: 9369285
[TBL] [Abstract][Full Text] [Related]
4. The influence of candesartan and PD123319 on responses to angiotensin II in the hindquarters vascular bed of the rat.
Champion HC; Bivalacqua TJ; Lambert DG; McNamara DB; Kadowitz PJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S95-7. PubMed ID: 9892147
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed.
Osei SY; Minkes RK; Bellan JA; Kadowitz PJ
J Pharmacol Exp Ther; 1993 Mar; 264(3):1104-12. PubMed ID: 8450454
[TBL] [Abstract][Full Text] [Related]
6. Analysis of effects of bosentan (Ro 47-0203), a nonpeptide endothelin ETA/ETB receptor antagonist, in the hind-limb vascular bed of the cat.
Champion HC; Estrada LS; Estrada LN; Filep JG; Kadowitz PJ
Can J Physiol Pharmacol; 1998 Feb; 76(2):141-7. PubMed ID: 9635152
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
[TBL] [Abstract][Full Text] [Related]
8. Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats.
Cervenka L; Wang CT; Navar LG
Am J Physiol; 1998 May; 274(5):F940-5. PubMed ID: 9612332
[TBL] [Abstract][Full Text] [Related]
9. Responses to angiotensin peptides are mediated by AT1 receptors in the rat.
Champion HC; Czapla MA; Kadowitz PJ
Am J Physiol; 1998 Jan; 274(1):E115-23. PubMed ID: 9458756
[TBL] [Abstract][Full Text] [Related]
10. The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cells.
Vauquelin G; Fierens FL; De Backer JP; Vanderheyden PM
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S15-7. PubMed ID: 9892135
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of DuP 753 and EXP3174 on responses to angiotensin II in pulmonary vascular bed of the cat.
McMahon TJ; Kaye AD; Hood JS; Minkes RK; Nossaman BD; Kadowitz PJ
J Appl Physiol (1985); 1992 Nov; 73(5):2054-61. PubMed ID: 1474085
[TBL] [Abstract][Full Text] [Related]
12. Analysis of responses to angiotensin peptides in the hindquarters vascular bed of the cat.
Garrison EA; Santiago JA; Osei SY; Kadowitz PJ
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2418-25. PubMed ID: 7611494
[TBL] [Abstract][Full Text] [Related]
13. The angiotensin II AT1 receptor antagonist irbesartan prevents thromboxane A2-induced vasoconstriction in the rat hind-limb vascular bed in vivo.
Fukuhara M; Neves LA; Li P; Diz DI; Ferrario CM; Brosnihan KB
J Hypertens; 2001 Mar; 19(3 Pt 2):561-6. PubMed ID: 11327630
[TBL] [Abstract][Full Text] [Related]
14. Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetil.
Unger T
Blood Press Suppl; 2000; 1():14-8. PubMed ID: 11059630
[TBL] [Abstract][Full Text] [Related]
15. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds.
Osei SY; Ahima RS; Minkes RK; Weaver JP; Khosla MC; Kadowitz PJ
Eur J Pharmacol; 1993 Mar; 234(1):35-42. PubMed ID: 7682513
[TBL] [Abstract][Full Text] [Related]
16. Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice.
Ruan X; Purdy KE; Oliverio MI; Coffman TM; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S202-7. PubMed ID: 9892164
[TBL] [Abstract][Full Text] [Related]
17. Renal responses of the nonclipped kidney of two-kidney/one-clip Goldblatt hypertensive rats to type 1 angiotensin II receptor blockade with candesartan.
Cervenka L; Navar LG
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S197-201. PubMed ID: 9892163
[TBL] [Abstract][Full Text] [Related]
18. [Pro11,D-Ala12]angiotensin I has rapid onset vasoconstrictor activity in the cat.
Garrison EA; Champion HC; Kadowitz PJ
Am J Physiol; 1997 Dec; 273(6):E1059-64. PubMed ID: 9435519
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological profiles of candesartan cilexetil (TCV-116)].
Inada Y
Nihon Rinsho; 1999 May; 57(5):1130-6. PubMed ID: 10361446
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
